Conditions: Advanced Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma; Hepatocellular Carcinoma; Liver Cancer; Liver Neoplasms; Hepatic Cancer; Hepatic Carcinoma; Cholangiocarcinoma; Bile Duct Cancer
Intervention: Drug: H3B-6527
Sponsors: H3 Biomedicine Inc.; Eisai Inc.
Recruiting